Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 7 | 2023 | 26 | 2.120 |
Why?
|
| Cochlear Implants | 7 | 2023 | 30 | 2.040 |
Why?
|
| Dizziness | 3 | 2021 | 16 | 1.630 |
Why?
|
| Hearing Loss, Sensorineural | 4 | 2023 | 47 | 1.250 |
Why?
|
| Cognitive Dysfunction | 2 | 2022 | 309 | 1.210 |
Why?
|
| Otologic Surgical Procedures | 3 | 2021 | 18 | 1.060 |
Why?
|
| Mastoidectomy | 3 | 2021 | 6 | 1.060 |
Why?
|
| Music | 4 | 2023 | 78 | 1.060 |
Why?
|
| Otolaryngology | 3 | 2021 | 24 | 1.040 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2025 | 1 | 0.960 |
Why?
|
| Meniere Disease | 2 | 2022 | 13 | 0.950 |
Why?
|
| Speech Perception | 3 | 2023 | 79 | 0.940 |
Why?
|
| Hearing Loss, Sudden | 2 | 2022 | 4 | 0.920 |
Why?
|
| Aerosols | 3 | 2021 | 40 | 0.910 |
Why?
|
| Smartphone | 1 | 2025 | 64 | 0.900 |
Why?
|
| Pitch Perception | 3 | 2023 | 24 | 0.840 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 191 | 0.840 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 204 | 0.830 |
Why?
|
| Tinnitus | 2 | 2023 | 16 | 0.830 |
Why?
|
| Bilateral Vestibulopathy | 1 | 2022 | 1 | 0.820 |
Why?
|
| Personal Protective Equipment | 4 | 2021 | 29 | 0.810 |
Why?
|
| Vestibular Diseases | 1 | 2022 | 9 | 0.800 |
Why?
|
| Deafness | 2 | 2023 | 32 | 0.800 |
Why?
|
| Spatial Navigation | 1 | 2022 | 7 | 0.800 |
Why?
|
| Physical Examination | 2 | 2021 | 103 | 0.780 |
Why?
|
| Vertigo | 1 | 2021 | 17 | 0.740 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2021 | 3 | 0.730 |
Why?
|
| Migraine Disorders | 1 | 2021 | 39 | 0.720 |
Why?
|
| Biological Products | 1 | 2022 | 90 | 0.720 |
Why?
|
| Ear Diseases | 1 | 2020 | 11 | 0.700 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 20 | 0.680 |
Why?
|
| Betacoronavirus | 3 | 2020 | 166 | 0.680 |
Why?
|
| Algorithms | 2 | 2025 | 976 | 0.640 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2019 | 7 | 0.630 |
Why?
|
| Telemedicine | 2 | 2021 | 307 | 0.620 |
Why?
|
| Wound Healing | 1 | 2019 | 174 | 0.570 |
Why?
|
| Pandemics | 6 | 2021 | 614 | 0.480 |
Why?
|
| Humans | 30 | 2025 | 59280 | 0.470 |
Why?
|
| Prospective Studies | 5 | 2025 | 3065 | 0.460 |
Why?
|
| Primary Health Care | 1 | 2018 | 643 | 0.410 |
Why?
|
| Otitis Media | 2 | 2022 | 10 | 0.390 |
Why?
|
| Auditory Perception | 4 | 2023 | 33 | 0.370 |
Why?
|
| Mastoid | 2 | 2020 | 9 | 0.350 |
Why?
|
| Retrospective Studies | 6 | 2023 | 6070 | 0.300 |
Why?
|
| Adult | 9 | 2025 | 15662 | 0.300 |
Why?
|
| Cognition | 2 | 2022 | 455 | 0.300 |
Why?
|
| Pleasure | 2 | 2015 | 13 | 0.250 |
Why?
|
| Healthy Volunteers | 1 | 2025 | 66 | 0.240 |
Why?
|
| Semicircular Canals | 2 | 2022 | 11 | 0.230 |
Why?
|
| Otolaryngologists | 2 | 2021 | 4 | 0.230 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 2373 | 0.220 |
Why?
|
| Endoscopy | 2 | 2021 | 98 | 0.220 |
Why?
|
| Cadaver | 2 | 2020 | 110 | 0.210 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2023 | 3 | 0.210 |
Why?
|
| Vestibule, Labyrinth | 1 | 2022 | 7 | 0.210 |
Why?
|
| Tympanic Membrane | 2 | 2021 | 10 | 0.210 |
Why?
|
| Vasculitis | 1 | 2023 | 50 | 0.200 |
Why?
|
| Rheumatic Diseases | 1 | 2023 | 38 | 0.200 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2021 | 26 | 0.200 |
Why?
|
| Executive Function | 1 | 2022 | 61 | 0.200 |
Why?
|
| Osteomyelitis | 1 | 2022 | 23 | 0.190 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2021 | 9 | 0.190 |
Why?
|
| Vestibular Function Tests | 1 | 2021 | 4 | 0.190 |
Why?
|
| Male | 8 | 2025 | 27726 | 0.190 |
Why?
|
| Acoustic Stimulation | 2 | 2019 | 50 | 0.190 |
Why?
|
| Eustachian Tube | 1 | 2021 | 8 | 0.190 |
Why?
|
| Nasopharynx | 1 | 2021 | 20 | 0.180 |
Why?
|
| Medical History Taking | 1 | 2021 | 64 | 0.180 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 220 | 0.180 |
Why?
|
| Quality of Life | 3 | 2023 | 1137 | 0.180 |
Why?
|
| Salivary Glands | 1 | 2021 | 46 | 0.180 |
Why?
|
| Neurotology | 1 | 2020 | 5 | 0.180 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 371 | 0.180 |
Why?
|
| Vaccines | 1 | 2022 | 95 | 0.180 |
Why?
|
| Middle Aged | 5 | 2025 | 16310 | 0.160 |
Why?
|
| Female | 7 | 2025 | 30694 | 0.160 |
Why?
|
| Occupational Exposure | 1 | 2020 | 306 | 0.140 |
Why?
|
| Comorbidity | 1 | 2020 | 1078 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2019 | 940 | 0.120 |
Why?
|
| Animals | 3 | 2022 | 19601 | 0.120 |
Why?
|
| Operating Rooms | 2 | 2020 | 55 | 0.080 |
Why?
|
| Aged | 3 | 2022 | 13411 | 0.080 |
Why?
|
| Mice | 1 | 2019 | 10251 | 0.060 |
Why?
|
| Hearing | 1 | 2023 | 30 | 0.050 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2023 | 2 | 0.050 |
Why?
|
| Pharynx | 1 | 2023 | 21 | 0.050 |
Why?
|
| Otolithic Membrane | 1 | 2022 | 2 | 0.050 |
Why?
|
| Dilatation | 1 | 2022 | 30 | 0.050 |
Why?
|
| Cochlea | 1 | 2022 | 22 | 0.050 |
Why?
|
| Skull Base | 1 | 2022 | 13 | 0.050 |
Why?
|
| Debridement | 1 | 2022 | 30 | 0.050 |
Why?
|
| Otoscopy | 1 | 2021 | 4 | 0.050 |
Why?
|
| Ear Canal | 1 | 2021 | 9 | 0.050 |
Why?
|
| Audiometry | 1 | 2021 | 17 | 0.050 |
Why?
|
| Auditory Threshold | 1 | 2021 | 26 | 0.050 |
Why?
|
| Ear, Middle | 1 | 2021 | 21 | 0.050 |
Why?
|
| Fluorescein | 1 | 2020 | 13 | 0.040 |
Why?
|
| Temporal Bone | 1 | 2020 | 37 | 0.040 |
Why?
|
| Simulation Training | 1 | 2021 | 61 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2023 | 1050 | 0.040 |
Why?
|
| Microscopy | 1 | 2020 | 88 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 333 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 168 | 0.040 |
Why?
|
| Occupational Health | 1 | 2020 | 180 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 914 | 0.040 |
Why?
|
| Surgeons | 1 | 2020 | 161 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 705 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 730 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2021 | 682 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1094 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 1524 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2511 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 1920 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2023 | 5283 | 0.020 |
Why?
|
| United States | 1 | 2020 | 7384 | 0.020 |
Why?
|